BTBağış Taşdoğan

Bağış Taşdoğan

*This is an algorithmically generated author record based on publicly available information.

Bağış Taşdoğan has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of routine four-quadrant re-excision in patients undergoing breast-conserving surgery

    by Cemal Hacıalioğlu, Hasan Ediz Sıkar, Bağış Taşdoğan, Yasin Tosun, Hasan Fehmi Küçük

    SUMMARY OBJECTIVE: The aim of this study was to evaluate the contribution of routine four-quadrant re-excision performed during breast-conserving surgery in detecting de novo tumor foci and ensuring negative surgical margins in patients with breast cancer. METHODS: A retrospective analysis was conducted on 44 female patients who underwent breast-conserving surgery between April 2021 and April 2023. In all cases, routine re-excision was performed in the superior, inferior, medial, and lateral quadrants during the same operative session. Based on pathological findings, patients with additional tumor foci in the re-excision specimens were classified as Group 1, while those without were classified as Group 2. RESULTS: The mean age of the patients was 54.2±11.6 years, with an average follow-up period of 21.5±8.3 months. Additional tumor foci were identified in seven patients (15.9%). There were no statistically significant differences between the groups in terms of age, tumor size, hormone receptor status, or histopathological characteristics (p>0.05). CONCLUSION: Routine four-quadrant re-excision may aid in the identification of microscopic de novo tumor foci even when clear surgical margins are achieved. However, larger multicenter studies with longer follow-up periods are warranted to determine its potential impact on local recurrence and long-term outcomes.

  • Treatment of Granulomatous Mastitis With Steroids: Should the Decision to End the Treatment be Made Radiologically?

    by Kenan Çetin, Hasan Ediz Sıkar, Fatih Feratoğlu, Bağış Taşdoğan, Bahadır M. Güllüoğlu

    Idiopathic granulomatous mastitis (IGM) is a benign inflammatory breast disease of unknown etiology that affects women in their reproductive period. The most commonly preferred option as first-line treatment is steroids, but the lack of a standard treatment protocol and high recurrence rate after treatment constitutes a recurring challenge during its management. The aim of this study was to investigate whether the decision to end the treatment should be made radiologically or clinically. This retrospective cohort study included IGM patients who had complete clinical recovery with steroids and were followed for a minimum of 30 months. Patient demographics, disease severity and findings, treatment regimens and duration, and magnetic resonance imaging (MRI) findings at clinical recovery were assessed for their relation to recurrence. Eighty-nine patients who were clinically completely healed after steroid treatment for IGM were included in the study. At the time of clinical healing, 51 (57.3%) patients had a complete radiological response and 38 (42.7%) had a partial radiological response (PRR) on MRI. Overall, recurrence developed in 22 (24.7%) patients after a median 38.6-month follow-up. Patients who experienced recurrence were significantly older and had PRR when their treatment was stopped upon clinical healing. During the process of clinical healing, the imaging findings revealed that the remaining disease seems to be a significant predictor for recurrence in IGM patients. In patients with PRR, extending the treatment with either prolonged steroid therapy or by surgical excision of the occult residual disease may prevent recurrences in IGM patients.


  • Open Access

    Diagnostic efficacy of physical examination and radiological findings in palpable breast masses

    by Ecem Memi̇şoğlu, Ramazan Sari, Yasin Tosun, Bağış TAŞDOĞAN, Günay Rona

    Aim: Clinical breast examination (CBE) is important in the early diagnosis of breast cancer, especially in low- and middleincome countries. Tru-cut biopsy (TCB) is the most used method for pathological diagnosis in patients with breast mass. This study aimed to evaluate the advantages and diagnostic accuracy of TCB decision based on CBE in patients presenting with a breast mass. Material and Methods: In this prospective cohort study, the data of patients who admitted to our outpatient breast clinic between September 2020 and March 2021 were evaluated. The presenting complaints, family history, hormone replacement treatment, mass size, contour, mobility, radiological findings, BI-RADS classification, and pathological diagnosis of TCB were recorded. Two hundred- two patients who underwent TCB in our outpatient breast clinic were included in the study. Results: The presence of irregular and fixed mass was mainly observed in the malignant group compared to the benign group (67.1% vs 43.9%, P: 0.001; 75.9% vs 39%, P< 0.001, respectively). In regression analysis, age was significantly associated with breast malignancy (OR: 1.12, CI %95: 1.06-1.18). CBE showed 85.5% consistency for benign pathology, 88.5% for malignancy, and 90.2% for granulomatous breast mass. Conclusion: The patients in advanced age and postmenopausal condition with irregularly, fixed breast mass in physical examination should be considered at high risk for breast cancer. TCB should be performed by experienced surgeons in lowmiddle-income countries and the diagnosis should be reached by reducing the long time and cost caused by radiology.

  • Meme Kanserinde Aksillanın Yönetimi

    by Hasan Uzer, Aytaç Emre Kocaoğlu, Saliha Karagöz Eren, Ali Can Yalı, Günay Rona, Meral Arifoğlu, Fırat Mülküt, İksan Taşdelen, Evrim Abamor, Gökhan Giray Akgül, et al.